PulseWave, a swiss company, is working on a wearable that can accurately diagnose arterial sclerosis.
PulseWave’s development, the TempleGuard, combines a wearable biosensor device worn conveniently and permanently with patients Eyeglasses and cloud-based data analytics with powerful proprietary algorithms that distill data millions of heartbeats into clinically actionable information.
Related Reading:
- Cardiologs AI platform + Apple Watch heart data for better cardiac health detection
- Facense Smartglasses for Health Monitoring can assist with blood pressure, blood sugar, and more
- Samsung SmartGlasses could help with medication reminders and other health information
Arterial Sclerosis is a common cardiac condition affecting more than three million people each year.
A build-up of cholesterol plaque in the walls of arteries obstructs blood flow. Atherosclerosis often has no symptoms until a plaque ruptures, or the buildup is severe enough to block blood flow.
Atherosclerosis happens when the endothelium becomes damaged due to factors such as smoking, high blood pressure, or high levels of glucose, fat, and cholesterol in the blood.
A healthy diet and exercise can help, and many treatments include medications and procedures to open blocked arteries and surgery.
Today there is no convenient wearable available on the market, which provides reliable and constant day-time cardiac indicators measurements to predict the development of arterial stiffness, coronary artery disease, and ischemic heart disease.
Most smartwatch-based wearables track heart rate metrics and certainly associate arrhythmias.
PulseWave believes improvements in arterial stiffness monitoring and characterization can change the clinical management of patients.
Eyeglasses are a very individual choice! Personal taste and fashion play an important role in the choice of an eyeglasses frame.
The company’s solution is an add-on to existing eyewear frames, elegantly hidden behind the ear and not influencing the comfort of wearing the frame in any way!
The central idea is that the sensors will contact the occipital artery right behind the ears, where the artery is twice as large as the radial artery, making it a better way to get readings as opposed to a smartwatch.
Pulsewave’s eyeglass add-on can sense crucial parameters such as ECG, PPT, PWV, and other readings that make it possible to predict a cardiac event.
This is an interesting case of a wearable where the form factor is leveraging a commonly used article used by many in their day-to-day lives, making it easier to adopt.
Source: Pulsewave
